Sherrie Jill Divito, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stevens-Johnson Syndrome | 4 | 2022 | 268 | 1.480 |
Why?
|
| Skin | 9 | 2021 | 4325 | 1.130 |
Why?
|
| Dapsone | 2 | 2019 | 62 | 0.880 |
Why?
|
| Dendritic Cells | 9 | 2019 | 2726 | 0.860 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2021 | 519 | 0.800 |
Why?
|
| Focal Dermal Hypoplasia | 2 | 2016 | 9 | 0.790 |
Why?
|
| Angiomatosis | 1 | 2020 | 49 | 0.780 |
Why?
|
| Skin Diseases, Vascular | 1 | 2020 | 41 | 0.750 |
Why?
|
| Plant Extracts | 2 | 2020 | 456 | 0.740 |
Why?
|
| Leprosy | 1 | 2019 | 126 | 0.720 |
Why?
|
| Graft vs Host Disease | 2 | 2020 | 2818 | 0.670 |
Why?
|
| Skin Diseases | 2 | 2020 | 1088 | 0.650 |
Why?
|
| Immunologic Memory | 3 | 2021 | 1391 | 0.650 |
Why?
|
| Cell Migration Assays | 1 | 2016 | 23 | 0.610 |
Why?
|
| Drug Hypersensitivity | 2 | 2022 | 865 | 0.590 |
Why?
|
| T-Lymphocytes | 7 | 2021 | 10362 | 0.580 |
Why?
|
| Herpesvirus 1, Human | 4 | 2010 | 727 | 0.500 |
Why?
|
| Keratitis, Herpetic | 3 | 2010 | 85 | 0.500 |
Why?
|
| Janus Kinases | 1 | 2014 | 209 | 0.500 |
Why?
|
| Alopecia Areata | 1 | 2014 | 95 | 0.480 |
Why?
|
| Antigens | 1 | 2019 | 1507 | 0.480 |
Why?
|
| Bone Diseases | 1 | 2016 | 423 | 0.470 |
Why?
|
| Immune Tolerance | 2 | 2019 | 2333 | 0.450 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2011 | 128 | 0.420 |
Why?
|
| Corneal Stroma | 2 | 2010 | 173 | 0.400 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2014 | 1897 | 0.360 |
Why?
|
| Cell Cycle | 1 | 2016 | 3014 | 0.320 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 3055 | 0.300 |
Why?
|
| Acute Disease | 1 | 2017 | 7158 | 0.300 |
Why?
|
| Dermatology | 1 | 2015 | 849 | 0.290 |
Why?
|
| Lymphocyte Activation | 5 | 2021 | 5908 | 0.280 |
Why?
|
| Immune System | 3 | 2015 | 806 | 0.260 |
Why?
|
| Antigen Presentation | 4 | 2019 | 1303 | 0.260 |
Why?
|
| Virus Activation | 1 | 2006 | 326 | 0.250 |
Why?
|
| Virus Latency | 1 | 2006 | 338 | 0.240 |
Why?
|
| Models, Immunological | 1 | 2006 | 529 | 0.240 |
Why?
|
| Biomedical Research | 2 | 2015 | 3266 | 0.240 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5135 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2017 | 4254 | 0.230 |
Why?
|
| Interleukin-15 | 2 | 2017 | 166 | 0.220 |
Why?
|
| Antigen-Presenting Cells | 2 | 2020 | 981 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2010 | 4383 | 0.210 |
Why?
|
| Exosomes | 2 | 2016 | 400 | 0.190 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10803 | 0.180 |
Why?
|
| Animals | 22 | 2021 | 170486 | 0.170 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2018 | 73 | 0.170 |
Why?
|
| Interferon-gamma | 4 | 2020 | 3245 | 0.170 |
Why?
|
| HLA-B Antigens | 1 | 2019 | 386 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5405 | 0.160 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1918 | 0.160 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 5266 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18375 | 0.150 |
Why?
|
| Mycosis Fungoides | 1 | 2018 | 153 | 0.150 |
Why?
|
| Isoantigens | 2 | 2010 | 579 | 0.150 |
Why?
|
| Mice, SCID | 2 | 2020 | 2835 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 6 | 2016 | 6684 | 0.150 |
Why?
|
| Melanoma | 2 | 2011 | 5194 | 0.150 |
Why?
|
| Mice, Inbred C3H | 3 | 2016 | 1021 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 386 | 0.140 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2015 | 80 | 0.140 |
Why?
|
| Nails | 1 | 2016 | 282 | 0.140 |
Why?
|
| Humans | 27 | 2022 | 708843 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1778 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2020 | 894 | 0.130 |
Why?
|
| Pemphigus | 1 | 2014 | 122 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 1224 | 0.130 |
Why?
|
| Mice | 15 | 2020 | 80876 | 0.120 |
Why?
|
| Hair | 1 | 2016 | 445 | 0.120 |
Why?
|
| Graft Rejection | 4 | 2016 | 4408 | 0.120 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 397 | 0.120 |
Why?
|
| Research | 1 | 2022 | 2009 | 0.120 |
Why?
|
| Chlorhexidine | 1 | 2014 | 132 | 0.120 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1924 | 0.120 |
Why?
|
| Mosaicism | 1 | 2015 | 450 | 0.110 |
Why?
|
| Sirolimus | 1 | 2020 | 1571 | 0.110 |
Why?
|
| Receptors, Tachykinin | 1 | 2011 | 24 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 234 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 239 | 0.110 |
Why?
|
| Nociceptors | 1 | 2015 | 427 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 9927 | 0.110 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1435 | 0.110 |
Why?
|
| Tachykinins | 1 | 2011 | 80 | 0.110 |
Why?
|
| Cytokines | 4 | 2017 | 7189 | 0.110 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2010 | 18 | 0.100 |
Why?
|
| Psoriasis | 2 | 2017 | 970 | 0.100 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2010 | 59 | 0.100 |
Why?
|
| Transplantation | 1 | 2012 | 228 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 2067 | 0.090 |
Why?
|
| Antimalarials | 1 | 2015 | 859 | 0.090 |
Why?
|
| Endosomes | 1 | 2011 | 531 | 0.090 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2117 | 0.090 |
Why?
|
| Chemokine CCL4 | 1 | 2008 | 114 | 0.090 |
Why?
|
| Transplantation, Homologous | 3 | 2016 | 4831 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 3490 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2020 | 2587 | 0.080 |
Why?
|
| Galectin 1 | 1 | 2009 | 135 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2008 | 80 | 0.080 |
Why?
|
| Nervous System | 1 | 2011 | 563 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1472 | 0.080 |
Why?
|
| Cell Division | 1 | 2016 | 4752 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1999 | 0.080 |
Why?
|
| Organ Transplantation | 2 | 2015 | 1071 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2020 | 3303 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2009 | 499 | 0.080 |
Why?
|
| Neurons | 1 | 2006 | 9385 | 0.070 |
Why?
|
| Flow Cytometry | 4 | 2012 | 6127 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 50597 | 0.070 |
Why?
|
| Dogs | 1 | 2010 | 4059 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2011 | 929 | 0.070 |
Why?
|
| DNA Primers | 1 | 2010 | 3002 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1192 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3708 | 0.070 |
Why?
|
| Cell Communication | 1 | 2011 | 1653 | 0.060 |
Why?
|
| Transplantation Tolerance | 1 | 2009 | 614 | 0.060 |
Why?
|
| Mast Cells | 1 | 2011 | 1601 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 2006 | 466 | 0.060 |
Why?
|
| Spleen | 3 | 2016 | 2473 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2010 | 2147 | 0.050 |
Why?
|
| Female | 13 | 2020 | 375205 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2010 | 15274 | 0.050 |
Why?
|
| Research Design | 1 | 2016 | 5833 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 22989 | 0.050 |
Why?
|
| Cornea | 1 | 2007 | 1458 | 0.040 |
Why?
|
| Neutrophils | 2 | 2010 | 3867 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2005 | 813 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 13352 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 8072 | 0.040 |
Why?
|
| Skin Transplantation | 2 | 2016 | 1130 | 0.040 |
Why?
|
| Vaccinia | 1 | 2017 | 81 | 0.040 |
Why?
|
| Heart Transplantation | 3 | 2016 | 3079 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 2734 | 0.040 |
Why?
|
| Male | 7 | 2020 | 349524 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 23020 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2011 | 8992 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4299 | 0.040 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2018 | 202 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2022 | 1549 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2011 | 3655 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2020 | 697 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2017 | 339 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 777 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 34261 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 319 | 0.030 |
Why?
|
| Apoptosis | 2 | 2009 | 10085 | 0.030 |
Why?
|
| Clone Cells | 1 | 2018 | 1767 | 0.030 |
Why?
|
| Transplants | 1 | 2016 | 202 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3354 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2005 | 1837 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 41081 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2015 | 305 | 0.030 |
Why?
|
| Adult | 5 | 2020 | 211041 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2014 | 401 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1434 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2498 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2016 | 1022 | 0.030 |
Why?
|
| Bandages | 1 | 2014 | 259 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11718 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 2014 | 350 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 2146 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3968 | 0.030 |
Why?
|
| Inflammation | 1 | 2011 | 10019 | 0.030 |
Why?
|
| Middle Aged | 5 | 2018 | 213752 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2325 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2011 | 265 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 4226 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 874 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2009 | 77 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1887 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 1922 | 0.020 |
Why?
|
| Child | 1 | 2016 | 73636 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 446 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 84718 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 938 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2221 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2010 | 638 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 23950 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3330 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 254 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 6156 | 0.020 |
Why?
|
| Graft Survival | 1 | 2016 | 3767 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2125 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 813 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2010 | 1082 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 58184 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3773 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12447 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 7989 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 5489 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2007 | 1499 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 4065 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 4116 | 0.010 |
Why?
|
| Critical Illness | 1 | 2014 | 2496 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8638 | 0.010 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 976 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 13274 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10507 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 28919 | 0.010 |
Why?
|
| Aged | 3 | 2015 | 161488 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12292 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 55940 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 14215 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9556 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 18748 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13298 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 9706 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2011 | 71483 | 0.000 |
Why?
|